Grants and Contracts Details
Description
UM1 Subcontract with the Markey Cancer Center at the University of Kentucky
Roles and areas of responsibility of the PI’s – Grever/OSU and DiPaola/UK
Serve on NCI’s IDB Steering Committee
Overall scientific and financial responsibility for the Phase I program
Overseeing the ETCTN clinical trials and patient accruals
Joint decision authority regarding selection of projects to pursue
Assign opportunities to investigators
Develop concepts and submit proposals for consideration to the IDB
Plan for teamwork
Drs. DiPaola and Arnold will “attend” weekly OSU meetings (by phone)
Additional leadership meetings will also be by phone (bi-weekly)
Meeting twice annually in person
Status | Finished |
---|---|
Effective start/end date | 4/1/16 → 2/28/18 |
Funding
- Ohio State University: $81,109.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.